Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.
A recent study also found that having a higher body mass index was associated with a higher risk of fatty liver disease.
Age, underlying medical conditions, race/ethnicity and economic status all play a role in determining the risk for severe illness.
John McLay reminds people aging with HIV that they are not alone and there are resources and people who can help.
As people with HIV live longer thanks to effective antiretroviral treatment, they are prone to a host of additional health problems.
High blood pressure, diabetes, lung disease and cardiovascular disease are all more prevalent among women with HIV.
A small study of people with HIV who did not have diabetes also found that 12 weeks of metformin improved gut microbiome health.
As with HIV-negative individuals, non-alcoholic fatty liver disease is tied to diabetes and irregular blood lipids in those with HIV.
People with cancer, heart disease and diabetes are at increased risk for serious illness from COVID-19.
Having an undetectable viral load did not change the risk, which nevertheless was not as severe as the risk tied to diabetes.
Non-alcoholic fatty liver disease is more common among those with the virus compared with the general population.
This finding, which is in keeping with initial studies out of China and Italy, is preliminary as the CDC continues to gather data.
Without swift unprecedented action, more than 2 million Americans could die.
Lower rates of targeted interventions and care strategies for acute heart problems compared with HIV-negative people are a likely factor.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.